Ensemtx
Cambridge, US · Founded 2021 · 20 employees on LinkedIn · 2 known investors
Find your way into Ensemtx
81 people in our graph share verified history with the Ensemtx team — schools, employers, funds. One of them is your warm intro.
René Kuijtenunlockedknows Shengfang Jin · together at Tufts University School of Medicine (overlapped)
×2knows the team · via Agios Pharmaceuticals
×2knows the team · via Harvard Medical School
×5knows the team · via Tufts University School of Medicine
×2knows the team · via Editas Medicine
Ensem Therapeutics is a drug discovery and development company focused on oncology therapeutics, leveraging proprietary computational chemistry and protein structural dynamics platforms. The company advances small molecule and targeted therapies from discovery through clinical development.
Founders & leadership
Ensemtx was founded in 2021 by Shengfang Jin.
SJ
Shengfang JininPresident and CEO, Board of DirectorShengfang Jin is President and CEO of Ensem Therapeutics, a drug discovery company developing oncology therapeutics. With over 25 years of biotech research experience in the Greater Boston area, he has led teams in developing small molecules and therapies for cancer and rare genetic diseases.
Investors · 2
Frequently asked questions
- What does Ensemtx do?
- Ensem Therapeutics is a drug discovery and development company focused on oncology therapeutics, leveraging proprietary computational chemistry and protein structural dynamics platforms. The company advances small molecule and targeted therapies from discovery through clinical development.
- Who founded Ensemtx?
- Ensemtx was founded by Shengfang Jin in 2021.
- Who are Ensemtx's investors?
- Ensemtx's investors include GGV Capital, Cenova Capital.
- Where is Ensemtx headquartered?
- Ensemtx is headquartered in Cambridge, US.